Critical review of EU BE guideline (Rev.1), tmax, MRT, LZ [Regulatives / Guidelines]

posted by d_labes  – Berlin, Germany, 2008-08-25 13:32 (6141 d 15:39 ago) – Posting: # 2248
Views: 24,386

Dear all!

to have it all in one place I transfer it from this thread:

Statistical analysis, page 13 (lines 504-505)
A nonparametric analysis is not acceptable.

This cannot be discussed seriously without crying.

Moreover in the text any statistical analysis of tmax has be gone.
It is only under named 4.1.5 Characteristics to be investigated page 9, but not further.
See also HS entry post of this thread.

Also note that MRT has disappeared.
Newly mentioned is LambdaZ, which is nearly the same, but on an inverse scale, as half live t1/2.

Regards,

Detlew

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,674 registered users;
47 visitors (0 registered, 47 guests [including 10 identified bots]).
Forum time: 05:11 CEST (Europe/Vienna)

Philosophy, like medicine, has plenty of drugs, few good remedies,
and hardly any specific cures.    Sebastien-Roch Nicolas de Chamfort

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5